Your browser needs updating!

It looks like you're using an old version of browser.

You can use the following links to update your browser::

Russian version ISSN: 2686-6706 (Print) ISSN: 2686-6714 (Online) Subscription index: 65055
'Science Management and Scientometrics' Journal
Dear authors and readers!
Starting from the issue 2, 2019 the name of the scientific journal
has been changed.
The new name of the journal is "Science Governance and Scientometrics".
The journal continues to be indexed in all declared databases.

The Foresight for Practical Realization of Research in Regenerative Medicine and Cell Technologies

Zyuz’kov G.N.

DOI: 10.33873/1996-9953.2019.14-1.42-69

Volume 14, issue 1/2019

Full article in PDF :


Introduction. The purpose of this article is to identify the most promisingwith regard to practical implementation trends in the ield of regenerative medicine and cell technologies.

Methods. The article presents the analysis of literature, including bibliographic publication sets (2012–2017) of the SciVal Spotlight (Elsevier), as well as the results of machining, aggregation and structuring of market intelligence databases (Gartner, Forrester, Markets and Markets, Research and Markets).

Results and Discussion. The most actively developing scientiic topics are revealed. Taking into account the existing knowledge in this interdisciplinary ield of science, socio-economic factors and the potential of the legal base, an objective assessment of the possibility to obtain practical results for wide use in medical services is given for the irst time. The author identiies insurmountable in the medium term barriers for large-scale clinical application of diferent biomedical cell products in regenerative medicine and oncology.

Coclusion. It is concluded that the most signiicant (in terms of potential contribution to the real sector of the economy in the medium and long term) areas of research and development should be considered the topics related to pharmacological strategy of regenerative medicine and the development of decellularized matrices within the use of tissue engineering technology. These indings must be taken into account when developing new and adjusting existing state programs for realization of the national project Science. When strategic planning of infrastructural, inancial and other kinds of support of the research in the ield of regenerative medicine and cell technologies it is reasonable to allocate ixed assets in favor of the identiied most promising research areas.


Regenerative medicine, cell technologies, tissue technologies, stem cells, pharmacology, biomedical cell products, SciVal

Information about the authors

Gleb N. Zyuz’kov, Habilitation Degree in Medicine, Professor of the Russian Academy of Sciences, Scientiic Secretary of the Institute, Head of the Laboratory of Pathophysiology and Experimental Therapy (Goldberg Research Institute of Pharmacology and Regenerative Medicine), Tomsk National Research Medical Center (1 Nakhimova St., Tomsk 634034, Russia). ORCID: The author’s main area of research is the role of progenitor cells of diferent classes in the development and resolution of pathological processes and the development of approaches and tools for regenerative medicine.

Full article in PDF :